|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
TRASTUZUMAB |
L01XC03 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
ADAGRASIB |
L01XX77 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
ETRASIMOD |
L04AE05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
SPARSENTAN |
C09XX01 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005783 |
19-04-2024 |
VALID
|
|
AZTREONAM AND BETA-LACTAMASE INHIBITOR |
J01DF51 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006113 |
22-04-2024 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
IPTACOPAN |
L04AJ08 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005764 |
17-05-2024 |
VALID
|
|
BEVACIZUMAB |
S01LA08 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005723 |
27-05-2024 |
VALID
|
|
DOPAMINE |
C01CA04 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006044 |
27-05-2024 |
VALID
|
|
DANTROLENE |
M03CA01 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006009 |
29-05-2024 |
VALID
|
|
TOFERSEN |
N07XX22 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005493 |
29-05-2024 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
CAPIVASERTIB |
L01EX27 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
CHIKUNGUNYA VACCINES |
J07BX07 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/005797 |
28-06-2024 |
VALID
|
|
DASIGLUCAGON |
H04AA02 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006214 |
24-07-2024 |
VALID
|
|
FIDANACOGENE ELAPARVOVEC |
B02BD17 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/004774 |
24-07-2024 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
FLORTAUCIPIR (18F) |
V09AX07 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006064 |
22-08-2024 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
DELGOCITINIB |
D11AH11 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006109 |
19-09-2024 |
VALID
|
|
ELAFIBRANOR |
A05AX06 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006231 |
19-09-2024 |
VALID
|
|
MARSTACIMAB |
B02BX11 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/006240 |
19-09-2024 |
VALID
|
|
MIRVETUXIMAB SORAVTANSINE |
L01FX26 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/005036 |
14-11-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) |
J07BB02 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006538 |
15-11-2024 |
VALID
|
|
CONCIZUMAB |
B02BX10 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/005938 |
13-12-2024 |
VALID
|
|
REPOTRECTINIB |
L01EX28 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006005 |
13-01-2025 |
VALID
|
|
VILOBELIMAB |
L04AJ10 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006123 |
13-01-2025 |
VALID
|
|
LAZERTINIB |
L01EB09 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006074 |
20-01-2025 |
VALID
|
|
SIPAVIBART |
J06BD09 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006291 |
20-01-2025 |
VALID
|
|
SERPLULIMAB |
L01FF12 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006170 |
03-02-2025 |
VALID
|
|
ACORAMIDIS |
C01EB25 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006333 |
10-02-2025 |
VALID
|
|
CATUMAXOMAB |
L01FX03 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/005697 |
10-02-2025 |
VALID
|
|
GARADACIMAB |
B06AC07 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/006116 |
10-02-2025 |
VALID
|
|
NEMOLIZUMAB |
D11AH12 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/006149 |
12-02-2025 |
VALID
|
|
TIRATRICOL |
H03AA04 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/005220 |
12-02-2025 |
VALID
|
|
EPLONTERSEN |
N07XX21 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/006295 |
06-03-2025 |
VALID
|
|
IMETELSTAT |
L01XX80 |
DE
|
Not authorised
|
02-05-2025 |
EMEA/H/C/006105 |
07-03-2025 |
VALID
|
|
4-DIMETHYLAMINOPHENOL |
V03AB27 |
DE
|
POM
|
23-10-2019 |
|
|
VALID
|
